Advances in Oncology, E-Book 2022
Contains 27 articles on such topics as proton radiotherapy for CNS malignancies; updates on neoadjuvant therapy for resectable and borderline resectable pancreatic cancer; NTRK inhibitors in adult patients with solid tumors; and health care disparities in gynecologic cancers.
Includes articles in the areas of radiation oncology, surgical oncology, medical oncology, gynecologic oncology, pediatric oncology, neuro-oncology, hematological oncology, uro-oncology, and gastrointestinal oncology.
Provides in-depth, clinical reviews in oncology, providing actionable insights for clinical practice.
Presents the latest information in the field under the leadership of an experienced editorial team. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.
|Author Information||Edited by Leonidas C. Platanias, M.D., Ph.D, Director, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Professor of Medicine (Hematology and Oncology) and Biochemistry and Molecular Genetics 312-908-5250|
|Table of Content||Neoadjuvant Chemotherapy for Nonmetastatic Breast Cancer: How Response Impacts Locoregional and Adjuvant Systemic Therapy Decision Making
Contemporary Multimodal Management of Primary Retroperitoneal Sarcomas
NTRK Inhibitors in Adult Patients with Solid Tumors
The Landscape of Personalized Medicine in Gynecologic Cancer
Geriatric Assessments: Tools for Every Oncologist to Stage the Aging When Caring for Older Adults with Cancer
Sentinel Lymph Node Sampling in Endometrial Cancers
Health Care Disparities in Gynecologic Oncology
Clinical Trials of Oncolytic Viruses in Glioblastoma
Circulating Tumor Cells and Cell-free Tumor DNA in Evaluation and Management of Gliomas: Current Evidence and Potential Future Clinical Use
Optimizing Hematopoietic Cellular Transplantation in Older Adults with Hematologic Malignancies
Moving Toward a Cure in Multiple Myeloma:Eradication of Measurable Residual Disease
Advances in Janus-Associated Kinase Inhibitor-Based Therapies for Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
Deoxyribonucleic Acid Damage Response Defects: Clinical Implications and the Role of Poly-ADP Ribose Polymerase Inhibitors in Genitourinary Cancers and Beyond
Clinical Trial Considerations for Bladder Preservation in Muscle-Invasive Bladder Cancer
The Changing Demographics of Colorectal Cancer: Rising Incidence in Younger Individuals
Total Neoadjuvant Strategies for Locally Advanced Rectal Cancer